| Literature DB >> 33153992 |
Takuhei Shoji1, Junji Kanno2, Robert N Weinreb3, Yuji Yoshikawa2, Izumi Mine2, Hirokazu Ishii2, Hisashi Ibuki2, Kei Shinoda2.
Abstract
BACKGROUND/AIMS: To evaluate quantitative changes in the foveal avascular zone (FAZ) area after glaucoma surgery using swept-source optical coherence tomography angiography (SS-OCTA).Entities:
Keywords: Anatomy; Glaucoma; Imaging; Retina
Mesh:
Year: 2020 PMID: 33153992 PMCID: PMC8685609 DOI: 10.1136/bjophthalmol-2020-317038
Source DB: PubMed Journal: Br J Ophthalmol ISSN: 0007-1161 Impact factor: 4.638
Demographics and ocular characteristics of the study population
| Surgery group | Non-surgery group | P value | |
|---|---|---|---|
| Patients (n) | 54 | ||
| Age (years) | 66.7±11.3 | ||
| Gender (male/female) | 25/29 | ||
| Eyes (n) | 54 | 54 | |
| BCVA (LogMAR) | 0.09 (−0.08, 0.24) | 0.00 (−0.08, 0.09) | 0.047 |
| CCT (μm) | 506±35 | 512±32 | 0.061 |
| Axial length (mm) | 24.9±1.7 | 24.9±1.7 | 0.932 |
| Preoperative IOP (mmHg) | 22.1±9.5 | 16.9±4.4 | <0.001 |
| Postoperative IOP (mmHg) | 10.3±3.5 | 16.5±3.5 | <0.001 |
| HFA 24-2 MD (dB) | −17.4 (−24.5, −11.0) | −8.5 (−16.1, −1.7) | <0.001 |
| Central-4-point mean sensitivity (dB) | 24.2 (18.2, 27.0) | 30.8 (27.2, 33.7) | <0.001 |
| Foveal sensitivity (dB) | 32.0 (29.0, 35.0) | 35.0 (30.0, 36.25) | 0.072 |
| Preoperative image score | 9.1±0.7 | 9.1±0.7 | 0.727 |
| Postoperative image score | 9.0±0.7 | 9.2±0.6 | 0.077 |
| Preoperative vessel density (%) | 41.4±5.0 | 42.3±5.8 | 0.157 |
| Combined cataract surgery, n (%) | 31 (57.4) | n.a. | |
| Type of glaucoma surgery, n (%) | n.a. | ||
| Ab interno trabeculotomy | 12 (22.2) | ||
| Filtering surgery | 40 (74.1) | ||
| Tube shunt (Ahmed glaucoma valve) | 2 (3.7) | ||
| Medications | |||
| Preoperative β-blocker, n (%) | 44 (81.5) | 35 (64.8) | <0.001 |
| Preoperative PG analogue, n (%) | 51 (94.4) | 39 (72.2) | <0.001 |
| Postoperative β-blocker, n (%) | 8 (14.8) | 28 (51.8) | <0.001 |
| Postoperative PG analogue, n (%) | 9 (16.7) | 30 (55.6) | <0.001 |
For normally distributed variables, results are shown as mean±SD; for non-normally distributed variables, results are shown as median (IQR). Data expressed as mean±SD were compared with paired t-test. Data expressed as the median (IQR) were compared using the non-parametric Wilcoxon signed-rank test. McNemar’s test was used to compare the frequencies of medication use between surgery group and non-surgery group.
BCVA, best correlated visual acuity; CCT, central corneal thickness; HFA, Humphrey field analyser; IOL, intraocular lens; IOP, intraocular pressure; LogMAR, logarithm of the minimum angle of resolution; MD, mean deviation; n.a, not applicable; PG, prostaglandin; SE, spherical equivalent.
Glaucoma medication use in the surgery and non-surgery groups between the preoperative and postoperative status
| Medications | Preoperative use | Postoperative use | P value* | Discontinued/Started |
|---|---|---|---|---|
| Surgery group | ||||
| β-Blocker, n (%) | 44 (81.4) | 8 (14.8) | <0.001 | 37 (68.5)/1 (1.9) |
| PG analogue, n (%) | 51 (94.4) | 9 (16.7) | <0.001 | 42 (77.8)/0 (0) |
| CAI, n (%) | 47 (87.0) | 12 (22.2) | <0.001 | 37 (68.5)/2 (3.7) |
| α-Agonists, n (%) | 42 (77.8) | 1 (1.9) | <0.001 | 42 (77.8)/1 (1.9) |
| ROCK inhibitor, n (%) | 30 (55.6) | 3 (5.6) | <0.001 | 29 (53.7)/2 (3.7) |
| Non-surgery group | ||||
| β-Blocker, n (%) | 35 (64.8) | 28 (51.8) | 0.065 | 9 (16.7)/2 (3.7) |
| PG analogue, n (%) | 39 (72.2) | 30 (55.6) | 0.023 | 11 (20.4)/2 (3.7) |
| CAI, n (%) | 37 (68.5) | 30 (55.6) | 0.065 | 9 (16.7)/2 (3.7) |
| α-Agonists, n (%) | 27 (50.0) | 21 (38.9) | 0.146 | 9 (16.7)/3 (5.6) |
| ROCK inhibitor, n (%) | 16 (29.6) | 14 (25.9) | 0.727 | 4 (7.4)/2 (3.7) |
*McNemar’s test was used to compare the frequencies of medication use between surgery and non-surgery groups and between preoperative and postoperative status.
CAI, carbonic anhydrase inhibitors; PG, prostaglandin; ROCK, Rho-associated coiled-coil-containing protein kinase.
Figure 1Representative cases from the surgery group of preoperative, postoperative and superimposition OCTA images. The preoperative OCTA images are shown in the first row. (upper right) Magnified view and extracted red-coloured FAZ boundary using the KSM program. The postoperative OCTA images are shown in the second row. (middle right) Magnified view and extracted pink-coloured FAZ boundary using the KSM program. The superimposition OCTA images are shown in the third row. These images comprise the comparison between the preoperative and postoperative OCTA images. (bottom centre) Inner plexus microvasculature could be confirmed in postoperative images (yellow arrow) even though this plexus microvasculature was not observable on the preoperative OCTA images. (bottom right) Superimposed images after extracting the FAZ boundary using an automated macro language. The postoperative FAZ area (blue-coloured extracted) was significantly smaller than the preoperative FAZ area (pink-coloured extracted). FAZ, foveal avascular zone; KSM, Kanno-Saitama Macro; OCTA, optical coherence tomography angiography.
FAZ area in the surgery group and non-surgery group between the preoperative and postoperative status
| FAZ area (mm2) | Preoperative | Postoperative | P value** |
|---|---|---|---|
| Surgery group | 0.485±0.193 | 0.446±0.174 | <0.001 |
| Non-surgery group | 0.398±0.119 | 0.396±0.110 | 0.469 |
| P value* | <0.001 | 0.019 |
* and **, paired t-test was used for both analysis.
FAZ, foveal avascular zone.
Figure 2Scatter plots showing the comparison between the preoperative and postoperative FAZ area in the surgery group and the non-surgery group, respectively. FAZ, foveal avascular zone.
Figure 3Distribution of change in the FAZ area in the surgery group and the non-surgery group. FAZ, foveal avascular zone.
Figure 4Box plots showing the comparison of the change in the FAZ area among non-surgery, glaucoma surgery–alone and glaucoma surgery combined with cataract surgery groups. FAZ, foveal avascular zone.
Association between the preoperative FAZ area and ocular variables: univariate and multivariable analyses (n=108 eyes)
| Preoperative FAZ area, mm2 | ||||||
|---|---|---|---|---|---|---|
| Univariate model | Multivariate model 1 | Multivariate model 2 | ||||
| Variables | Coefficients | P value | Coefficients | P value | Coefficients | P value |
| (95% CI) | (95% CI) | (95% CI) | ||||
| Age (years) per 10 years | 0.020 (−0.014 to 0.053) | 0.254 | −0.006 (−0.038 to 0.026) | 0.751 | −0.003 (−0.036 to 0.03) | 0.860 |
| Sex (male/female) | 0.058 (−0.017 to 0.133) | 0.129 | ||||
| CCT (μm) per 100 μm |
|
|
|
|
|
|
| Axial length (mm) per 1 mm | 0.033 (−0.194 to 0.259) | 0.777 | ||||
| Preoperative IOP (mmHg) per 10 mmHg | 0.013 (−0.024 to 0.049) | 0.496 | ||||
| HFA 24-2 MD (dB) per 10 dB | −0.040 (−0.069 to −0.01) | 0.008 | −0.006 (−0.039 to 0.026) | 0.701 | 0.015 (−0.029 to 0.058) | 0.512 |
| Foveal Sensitivity |
|
|
|
| ||
| Central-4point mean sensitivity |
|
|
|
| ||
| Topical glaucoma medications (yes/no) | ||||||
| β-Blocker | 0.049 (−0.017 to 0.115) | 0.144 | ||||
| PG analogue |
|
| 0.039 (−0.04 to 0.118) | 0.337 | 0.019 (−0.057 to 0.096) | 0.619 |
| CAI | 0.041 (−0.024 to 0.107) | 0.218 | ||||
| α-Agonists | 0.011 (−0.051 to 0.073) | 0.729 | ||||
| ROCK inhibitor | 0.024 (−0.036 to 0.084) | 0.436 | ||||
*p<0.10, univariate analysis.
**p<0.05, multivariate analysis.
CAI, carbonic anhydrase inhibitors; CCT, central corneal thickness; FAZ, foveal avascular zone; HFA, Humphrey field analyser; IOP, intraocular pressure; MD, mean deviation; PG, prostaglandin; ROCK, Rho-associated coiled-coil-containing protein kinase.
Association between change in the FAZ area and ocular variables: univariate and multivariable analyses (n=108 eyes)
| Change in the FAZ area, mm2 | ||||||
|---|---|---|---|---|---|---|
| Univariate model | Multivariate model 1 | Multivariate model 2 | ||||
| Variables | Coefficients | P value | Coefficients | P value | Coefficients | P value |
| (95% CI) | (95% CI) | (95% CI) | ||||
| Age (years) per 10 years | −0.002 (−0.010 to 0.007) | 0.667 | 0.006 (−0.026 to 0.038) | 0.154 | −0.005 (−0.013 to 0.003) | 0.244 |
| Gender (male/female) | 0.000 (−0.019 to 0.020) | 0.855 | ||||
| CCT (μm) per 100 μm |
|
| 0.113 (−0.013 to 0.214) | 0.103 | −0.021 (−0.005 to 0.047) | 0.108 |
| Axial length (mm) per 1 mm | −0.002 (−0.008 to 0.004) | 0.523 | ||||
| Foveal sensitivity |
|
|
|
|
|
|
| Preoperative FAZ area (mm2) per mm2 |
|
|
|
|
|
|
| Change in IOP (mmHg) per 10 mmHg |
|
|
|
| ||
| Surgery | ||||||
| Glaucoma surgery alone (yes/no) |
|
|
|
| ||
| Glaucoma surgery combined with cataract surgery (yes/no) |
|
|
|
| ||
*p<0.10, univariate analysis.
**p<0.05, multivariate analysis.
IOP, intraocular pressure; CCT, central corneal thickness; FAZ, foveal avascular zone; OCTA, optical coherence tomography angiography; PG, prostaglandin.